 DARTMOUTH, Nova Scotia, CAMBRIDGE, Mass.--BUSINESS WIRE--- IMV DeliveryPlatform--IMV Inc. Nasdaq: IMV; TSX: IMV, a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and hematologic cancers, today announced that members of IMVs executive management team will be presenting at two investor conferences in September. Please find additional details on the conferences below. H.C. Wainwright 24th Annual Global Investment Conference, New York City 